LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), a clinical-stage pharmaceutical company ...
MITOLINE™ Algorithm Powers Development of First-in-Class Small Molecules Targeting a Mitochondrial Carrier for Inflammatory ...
SHELTON, CT / ACCESS Newswire / January 20, 2026 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a clinical stage ...
Artificial intelligence (AI) is transforming the life sciences industry, with potentially its most significant impact on drug ...
"Star Trek" heroes are clever, but so are many of its villains. With vast knowledge and inhuman capabilities, they keep Starfleet — and viewers — on edge.
Morning Overview on MSN
Quantum-powered proteins could launch a shocking new biotech era
Quantum physics is no longer confined to cryogenic chips and vacuum chambers. It is starting to seep into the machinery of ...
SHELTON, CT / ACCESS Newswire / January 20, 2026 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus ...
A single enzyme that can generate all four nucleoside triphosphates, the building blocks of ribonucleic acid (RNA), has been identified by researchers at the Institute of Science Tokyo. The study was ...
AZoLifeSciences on MSN
MYC gene's dual role in cancer growth and immune suppression
The cancer gene MYC camouflages tumors by suppressing alarm signals that normally activate the immune system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results